Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Viva Biotech Successfully Held The 3rd Annual Partnership Summit 2022-06-23 20:30
I-Mab Receives Top Rankings in Five Categories by Institutional Investor 2022-06-23 20:00
Short Videos of Traditional Chinese Medicine Culture Go Viral on YouTube 2022-06-23 11:14
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials 2022-06-23 09:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-06-23 05:00
Scientists take the first step to master an all-powerful cell type in the beginning of life 2022-06-21 23:10
Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, "J INTS BIO's new oral administration 4th generation EGFR TKI 'JIN-A02' expected to be a game changer" 2022-06-21 17:00
Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging 2022-06-21 14:00
Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform 2022-06-21 08:00
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma 2022-06-20 20:00
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
Memorial MRI & Diagnostic Installs United Imaging's Pioneering 75 cm, Ultra-Wide-Bore uMR OMEGA™ 2022-06-17 21:00
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-06-17 20:00
Lunit Files Registration Statement for Initial Public Offering 2022-06-16 21:00
Bon Natural Life Limited Introduces New Powder Drink For Anti-H. Pylori and Digestive Health 2022-06-16 20:30
111, Inc. Announces First Quarter 2022 Unaudited Financial Results 2022-06-16 15:58
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies 2022-06-16 08:00
I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210 2022-06-15 22:37
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting 2022-06-15 20:01
1 151 152 153 154 155 811